Physician profile

Christopher Gomez

Dentist · Pensacola, FL

NPI 1518227933

$1,087.80

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Gift$590.00
Food and Beverage$93.58

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
A-Dec, INC. $590.00 2023
Peter Brasseler Holdings, LLC $219.00 2019
Biohorizons Implant Systems INC. $126.41 2020-2022
Patterson Companies, INC. $82.49 2022-2023
Envista Holdings Corporation $21.86 2024 Spark
Straumann USA LLC $19.23 2024
Zimmer Biomet Holdings, INC. $16.27 2019
Voco America INC. $12.54 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christopher Gomez

$1,087.80

in general payments reported 2019-2025

Years
2019-2024
Top company
A-Dec, INC.

https://glasscript.com/doctor/3215375/christopher-gomez

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.